查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1591779

心臟移植市场：按手术类型、最终用户划分 - 全球预测 2025-2030 年

Heart Transplant Market by Surgery Type (Biventricular Pacing, Total Artificial Heart, Ventricular Assist Devices), End User (Cardiac Institutes, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

心臟移植市场2023年估值为119.3亿美元，预计到2024年将达到131亿美元，复合年增长率为9.88%，预计到2030年将达到230.9亿美元。

心臟移植市场包括与用健康的捐赠心臟替换患者患病或衰竭的心臟相关的医疗技术和程序。心臟移植的需要源于对传统治疗没有反应的晚期心臟衰竭病例，这对于延长患者的生存至关重要。应用主要针对末期心臟疾病患者，健康和医疗部门是主要的最终用户。市场成长受到心血管疾病盛行率上升、外科技术进步、免疫抑制治疗改善、捐赠者意识提升计画增加等因素的影响。 3D 列印心臟等技术创新以及器官保存和运输方面的进步正在提高移植成功率并增加移植的地理范围，凸显了巨大的市场机会。挑战包括全球捐赠心臟短缺、移植手术成本高昂以及需要复杂的术后护理，这些可能导致治疗可用性的差异。有关器官捐赠的监管障碍和道德担忧使市场扩张更加复杂。为了解决这些障碍，技术创新的重点是人造心臟和异种移植（xenotransplants）的开发，这有望成为器官短缺的长期解决方案。重点研究微创手术技术、更好的免疫抑制剂，以及利用人工智慧进行患者选择和最佳捐赠者匹配，将为产业发展铺平道路。该市场竞争激烈、研究密集型，其特点是研究机构、医院和医疗保健公司之间因对永续和创新解决方案的需求而合作。要在这个市场保持领先地位，需要对研究和技术进行投资，以优化患者的治疗效果和捐赠器官的利用，以满足公司当前的需求和未来在心臟移植方面的挑战。

主要市场统计
基准年[2023] 119.3亿美元
预测年份 [2024] 131亿美元
预测年份 [2030] 230.9亿美元
复合年增长率（%） 9.88%

市场动态：揭示快速发展的心臟移植市场的关键市场洞察

供需的动态交互作用正在改变心臟移植市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 对改善和改善生活品质的需求不断增加
    • 随着世界老年人口的增加，心血管疾病的盛行率不断上升
    • 政府对研发活动的支持迅速增加
  • 市场限制因素
    • 缺乏熟练的外科医生和捐助者短缺
  • 市场机会
    • 新兴国家和已开发国家强劲的医疗保健支出
    • 机械循环支援装置等新应用
  • 市场挑战
    • 治疗费用上涨

波特五力：驾驭心臟移植市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解心臟移植市场的外部影响

外部宏观环境因素在塑造心臟移植市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解心臟移植市场的竞争格局

对心臟移植市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵心臟移植市场供应商的绩效评估

FPNV定位矩阵是评估心臟移植市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製心臟移植市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，心臟移植市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对改善和改善生活品质的需求不断增加
      • 全世界心血管疾病的盛行率正在上升，老年人口也在增加。
      • 政府对研发活动的支持迅速增加
    • 抑制因素
      • 缺乏熟练的外科医生和捐助者短缺
    • 机会
      • 开发中国家医疗保健支出的稳健性
      • 机械循环支援装置等新应用
    • 任务
      • 治疗费用高
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依手术类型分類的心臟移植市场

  • 双心室起搏
  • 全人工心臟
  • 辅助人工心臟

第七章心臟移植市场：依最终用户分类

  • 心臟病研究所
  • 医院

第八章美洲心臟移植市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区心臟移植市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲心臟移植市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Abiomed
  • Berlin Heart
  • Bivacor, Inc.
  • Boston Scientific Corporation
  • Calon Cardio-Technology Ltd.
  • CareDx, Inc.
  • Edwards Lifesciences
  • Fresenius Medical Care AG & Co. KGaA
  • GE Healthcare
  • Getinge AB
  • Jarvik Heart, Inc.
  • Johnson & Johnson Services, Inc.
  • LivaNova, Inc.
  • Medtronic PLC
  • SynCardia Systems, LLC
  • Terumo Europe NV
  • Thoratec Corporation
  • WL Gore & Associates
Product Code: MRR-437E9896A565

The Heart Transplant Market was valued at USD 11.93 billion in 2023, expected to reach USD 13.10 billion in 2024, and is projected to grow at a CAGR of 9.88%, to USD 23.09 billion by 2030.

The heart transplant market encompasses medical technologies and procedures associated with replacing a patient's diseased or failing heart with a healthy donor heart. The necessity for heart transplants is driven by advanced heart failure cases unresponsive to conventional treatments, making it crucial for extending patients' lives. Applications predominantly involve end-stage heart disease patients, making the health and medical sectors the primary end users. Market growth is influenced by factors such as rising incidences of cardiovascular diseases, advancement in surgical techniques, improved immunosuppressive therapies, and increased donor awareness programs. Innovations like 3D-printed hearts and advancements in organ preservation and transport underscore significant market opportunities, enhancing transplant success rates and increasing geographic accessibility to transplants. Challenges include a global shortage of donor hearts, high costs of transplant procedures, and complex post-operative care requirements, which can lead to disparities in treatment availability. Regulatory hurdles and ethical concerns regarding organ donation further complicate market expansion. To address these hurdles, innovation focuses on the development of artificial hearts and xenotransplantation (cross-species organ transplants), which promise a long-term solution to organ scarcity. Emphasizing research in minimally invasive surgical techniques, better immunosuppressive drugs, and harnessing AI for patient selection and optimum donor matching will provide avenues for industry advancement. The market nature is competitive and research-intensive, characterized by collaborations between research institutions, hospitals, and healthcare companies, driven by the need for sustainable and innovative solutions. Staying ahead in this market requires investing in research and technology that optimize patient outcomes and donor organ utilization, positioning businesses to meet both current demands and future challenges in heart transplants.

KEY MARKET STATISTICS
Base Year [2023] USD 11.93 billion
Estimated Year [2024] USD 13.10 billion
Forecast Year [2030] USD 23.09 billion
CAGR (%) 9.88%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Heart Transplant Market

The Heart Transplant Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for improved and extended quality of life
    • Rising prevalence of cardiovascular disease coupled with rising geriatric population globally
    • Surge in government support for R&D activities
  • Market Restraints
    • Dearth of skilled surgeons and shortage of donors
  • Market Opportunities
    • Robust healthcare expenditure in developing and developed countries
    • Emerging application of mechanical circulatory support assist devices and other such devices
  • Market Challenges
    • High cost of the treatment

Porter's Five Forces: A Strategic Tool for Navigating the Heart Transplant Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Heart Transplant Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Heart Transplant Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Heart Transplant Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Heart Transplant Market

A detailed market share analysis in the Heart Transplant Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Heart Transplant Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Heart Transplant Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Heart Transplant Market

A strategic analysis of the Heart Transplant Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Heart Transplant Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abiomed, Berlin Heart, Bivacor, Inc., Boston Scientific Corporation, Calon Cardio-Technology Ltd., CareDx, Inc., Edwards Lifesciences, Fresenius Medical Care AG & Co. KGaA, GE Healthcare, Getinge AB, Jarvik Heart, Inc., Johnson & Johnson Services, Inc., LivaNova, Inc., Medtronic PLC, SynCardia Systems, LLC, Terumo Europe N.V., Thoratec Corporation, and W. L. Gore & Associates.

Market Segmentation & Coverage

This research report categorizes the Heart Transplant Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Surgery Type, market is studied across Biventricular Pacing, Total Artificial Heart, and Ventricular Assist Devices.
  • Based on End User, market is studied across Cardiac Institutes and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for improved and extended quality of life
      • 5.1.1.2. Rising prevalence of cardiovascular disease coupled with rising geriatric population globally
      • 5.1.1.3. Surge in government support for R&D activities
    • 5.1.2. Restraints
      • 5.1.2.1. Dearth of skilled surgeons and shortage of donors
    • 5.1.3. Opportunities
      • 5.1.3.1. Robust healthcare expenditure in developing and developed countries
      • 5.1.3.2. Emerging application of mechanical circulatory support assist devices and other such devices
    • 5.1.4. Challenges
      • 5.1.4.1. High cost of the treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Heart Transplant Market, by Surgery Type

  • 6.1. Introduction
  • 6.2. Biventricular Pacing
  • 6.3. Total Artificial Heart
  • 6.4. Ventricular Assist Devices

7. Heart Transplant Market, by End User

  • 7.1. Introduction
  • 7.2. Cardiac Institutes
  • 7.3. Hospitals

8. Americas Heart Transplant Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Heart Transplant Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Heart Transplant Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Abiomed
  • 3. Berlin Heart
  • 4. Bivacor, Inc.
  • 5. Boston Scientific Corporation
  • 6. Calon Cardio-Technology Ltd.
  • 7. CareDx, Inc.
  • 8. Edwards Lifesciences
  • 9. Fresenius Medical Care AG & Co. KGaA
  • 10. GE Healthcare
  • 11. Getinge AB
  • 12. Jarvik Heart, Inc.
  • 13. Johnson & Johnson Services, Inc.
  • 14. LivaNova, Inc.
  • 15. Medtronic PLC
  • 16. SynCardia Systems, LLC
  • 17. Terumo Europe N.V.
  • 18. Thoratec Corporation
  • 19. W. L. Gore & Associates

LIST OF FIGURES

  • FIGURE 1. HEART TRANSPLANT MARKET RESEARCH PROCESS
  • FIGURE 2. HEART TRANSPLANT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEART TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HEART TRANSPLANT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HEART TRANSPLANT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEART TRANSPLANT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEART TRANSPLANT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEART TRANSPLANT MARKET DYNAMICS
  • TABLE 7. GLOBAL HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEART TRANSPLANT MARKET SIZE, BY BIVENTRICULAR PACING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEART TRANSPLANT MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEART TRANSPLANT MARKET SIZE, BY CARDIAC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEART TRANSPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. HEART TRANSPLANT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. HEART TRANSPLANT MARKET, FPNV POSITIONING MATRIX, 2023